Pregnancy and epilepsy-when you're managing both

Journal of Family Practice

Volumn 59, Issue 12, 2010, Pages 675-679

  Sethi, Nitin K ^a   Wasterlain, Amy ^a   Harden, Cynthia L ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PHYTOMENADIONE; TOPIRAMATE; VALPROIC ACID; VITAMIN K GROUP;

ANTICONVULSANT THERAPY; ARTICLE; BRADYCARDIA; BRAIN MALFORMATION; BREAST FEEDING; BREAST MILK; CLEFT PALATE; CLINICAL DECISION MAKING; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EXCRETION; DRUG INTOXICATION; DRUG MONITORING; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPSY; EVIDENCE BASED PRACTICE; FETAL HYDANTOIN SYNDROME; FIRST TRIMESTER PREGNANCY; GENERAL PRACTITIONER; GESTATION PERIOD; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PATIENT; HUMAN; HYPOSPADIAS; INDUCED HYPOTENSION; LIMB REDUCTION DEFECT; MEDICAL HISTORY; MONOTHERAPY; NEURAL TUBE DEFECT; OPTIMAL DRUG DOSE; PORENCEPHALY; PREGNANCY; PREGNANT WOMAN; PREPREGNANCY CARE; PYLORUS STENOSIS; SIDE EFFECT; SPINA BIFIDA; SPONTANEOUS ABORTION; TERATOGENESIS; TREATMENT PLANNING; UROGENITAL TRACT MALFORMATION; VITAMIN SUPPLEMENTATION;

ANTICONVULSANTS; EPILEPSY; FAMILY PRACTICE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 78650648954     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Harden CL, Meador KJ, Penneil PB, et al; American Academy of Neurology; American Epilepsy Society. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73:133-141.
2. Sachdeo R. The evidence-based rationale for monotherapy in appropriate patients with epilepsy. Neurology. 2007;69 (suppl 3):S1-S2.
3. Holmes GL, Harden C, Liporace J, et al. Postnatal concerns in children born to women with epilepsy. Epilepsy Behau. 2007;11:270-276.
4. Bromley RL, Baker GA, Meador KJ. Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol. 2009;22:162-166.
5. Yerby MS, Kaplan P, Tran T. Risks and management of pregnancy in women with epilepsy. Cleue Clin J Med. 2004;71 (suppl 2):S25-S37.
6. Samren EB, van Duijn CM, Koch S, et al. Maternal use of amiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia. 1997;38:981-990.
7. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci. 2002;99:15089-15094. (Pubitemid 35334614)
8. Katz I, Kim J, Gale K, et al. Effects of lamotrigine alone and in combination with MK-801, phénobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther. 2007;322:494-500. (Pubitemid 47105802)
9. Meador KJ, Baker GA, Finnell RH, et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology. 2006;67:407-412.
10. Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology. 2003;60:575-579.
11. Rasmussen MM, Clemmensen D. Folic acid supplementation in pregnant women. Dan Med Bull. 2010;57:A4134.
12. Pittschieier S, Brezmka C, Jahn B, et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol. 2008;255:1926-1931.
13. Epilepsy Foundation. Pregnancy & parenting. Available at: www.epilepsyfoundation.org/livtng/women/pregnancy/ weipregnancy.cfm. Accessed November 4, 2010.
14. Harden CL, Pennell PB, Koppel BS, et al; American Academy of Neurology; American Epilepsy Society. Practice parameter update: management issues for women with epilepsyfocus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73:142-149.
15. Tettenborn B. Management of epilepsy in women of childbearing age: practice recommendations. CNS Drugs. 2006; 20:373-387. (Pubitemid 43763738)
16. Harden CL, Hopp J, Ting TY, et al; American Academy of Neurology; American Epilepsy Society. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009; 73:126-132.
17. Kennedy F, Morrow J, Hunt S, et al. PATH39 malformation risks of antiepileptic drugs in pregnancy: an update from the UK Epilepsy and Pregnancy Registry. J Neurol Neurosurg Psychiatry. 2010;81:e18.
18. Ohman I, Beck O, Vitols S, et al. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia. 2008;49: 1075-1080.
19. Artama M, Anvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology. 2005;64:1874-1878.